脂质体多粘菌素B对耐药革兰氏阴性菌菌株的抗菌效果。

Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.

作者信息

Alipour Misagh, Halwani Majed, Omri Abdelwahab, Suntres Zacharias E

机构信息

Department of Chemistry and Biochemistry, Laurentian University, Sudbury, Ontario, Canada.

出版信息

Int J Pharm. 2008 May 1;355(1-2):293-8. doi: 10.1016/j.ijpharm.2007.11.035. Epub 2007 Nov 24.

Abstract

Polymyxin B is a polycationic antibiotic effective in the treatment of Gram-negative bacterial infections. Systemic use of polymyxin B has been limited due to its toxicity, most notably nephrotoxicity, ototoxicity, and neuromuscular blockade. Entrapment of antibiotics in liposomes is known to enhance their antimicrobial activities while minimizing their toxic effects. In the present study, polymyxin B was incorporated into liposomes composed of either 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and cholesterol (Chol) or 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and Chol. The entrapment efficiency of sonicated liposomes containing DPPC/Chol (32.1+/-2.43%) was six-fold higher than that of liposomes containing POPC/Chol (5.35+/-0.32%). On the other hand, the entrapment efficiency of extruded DPPC/Chol liposomes (3.23+/-0.46%) was about 30% less than that of liposomes composed of POPC/Chol (5.10+/-0.37%). Incubation of extruded DPPC/Chol liposomes containing polymyxin B in serum at 37 degrees C resulted in a complete release of the antibiotic into the supernatant after 3h as compared to 6h in the case of POPC/Chol liposomes. Spontaneous release of polymyxin B from DPPC/Chol liposomes incubated in saline was significantly higher (66%) than that from POPC/Chol liposomes (24%) after 48h at 37 degrees C. With respect to the antimicrobial activities of the liposomal polymyxin B formulations, the MICs of sonicated DPPC/Chol liposomes against Gram-negative strains were generally lower when compared to free polymyxin B. Immunocytochemistry and electron transmission microscopic studies revealed that the penetration of polymyxin B into a resistant strain of Pseudomonas aeruginosa was higher following its administration as a liposomal formulation as compared to its conventional form. The combination of free drug and plain liposomes had an antibacterial activity similar to that of free antibiotic. These data suggest that incorporation of polymyxin B in liposomes could be useful in the management of Gram-negative infections induced by these microorganisms.

摘要

多粘菌素B是一种聚阳离子抗生素,对治疗革兰氏阴性菌感染有效。由于其毒性,尤其是肾毒性、耳毒性和神经肌肉阻滞作用,多粘菌素B的全身应用受到限制。已知将抗生素包裹于脂质体中可增强其抗菌活性,同时将其毒性作用降至最低。在本研究中,多粘菌素B被包入由1,2 -二棕榈酰 - sn -甘油 - 3 -磷酸胆碱(DPPC)和胆固醇(Chol)或1 -棕榈酰 - 2 -油酰 - sn -甘油 - 3 -磷酸胆碱(POPC)和胆固醇组成的脂质体中。含有DPPC/Chol的超声处理脂质体的包封率(32.1±2.43%)比含有POPC/Chol的脂质体(5.35±0.32%)高6倍。另一方面,挤出的DPPC/Chol脂质体的包封率(3.23±0.46%)比由POPC/Chol组成的脂质体(5.10±0.37%)低约30%。将含有多粘菌素B的挤出DPPC/Chol脂质体于37℃在血清中孵育,3小时后抗生素完全释放到上清液中,而POPC/Chol脂质体则需要6小时。在37℃下于盐水中孵育48小时后,多粘菌素B从DPPC/Chol脂质体中的自发释放率(66%)显著高于从POPC/Chol脂质体中的自发释放率(24%)。关于脂质体多粘菌素B制剂的抗菌活性,与游离多粘菌素B相比,超声处理的DPPC/Chol脂质体对革兰氏阴性菌株的最低抑菌浓度通常较低。免疫细胞化学和电子透射显微镜研究表明,与传统形式相比,以脂质体制剂形式给药后,多粘菌素B对耐药铜绿假单胞菌菌株的渗透更高。游离药物与普通脂质体的组合具有与游离抗生素相似的抗菌活性。这些数据表明,将多粘菌素B包入脂质体可能有助于治疗由这些微生物引起的革兰氏阴性感染。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索